EUVIMEDEUVIMED entdecken
Open Access

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan

Kazunori Toyoda, Shuji Arakawa, Masayuki Ezura, Rei Kobayashi, Yoshihide Tanaka, Shu Hasegawa, Shigeo Yamashiro, Yoji Komatsu, Yuka Terasawa, Tomohiko Masuno, Hiroshi Kobayashi, Suzuko Oikawa und 1 weitere

Journal of Atherosclerosis and Thrombosis · 2024

DOI: 10.5551/jat.64223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2024. Verfasst von Kazunori Toyoda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center. Hauptthemen laut MEDLINE: Hemostatics, Thrombosis, Pyridines, Thiazoles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemostaticsThrombosisPyridinesThiazolesHumansFactor Xa InhibitorsRivaroxabanFactor XaJapanProspective StudiesHemorrhageAntithrombin IIIFibrinolytic AgentsRecombinant ProteinsAnticoagulants

Stichwörter der Autor:innen

AnticoagulationAntidoteAsianBleedingIntracranial hemorrhage

Substanzen

Factor Xa InhibitorsedoxabanRivaroxabanPRT064445Factor XaAntithrombin IIIHemostaticsFibrinolytic AgentsRecombinant ProteinsAnticoagulants

Autor:innen und Institutionen

  • Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center.
  • Department of Neurology, Steel Memorial Yawata Hospital.
  • National Hospital Organization Sendai Medical Center.
  • Department of Neurology, National Hospital Organization Nagoya Medical Center.
  • Yokosuka Kyosai Hospital.
  • Department of Neurosurgery, Japanese Red Cross Kumamoto Hospital.

Zitieren

APA

Toyoda, K., Arakawa, S., Ezura, M., Kobayashi, R., Tanaka, Y., Hasegawa, S., Yamashiro, S., Komatsu, Y., Terasawa, Y., Masuno, T., Kobayashi, H., Oikawa, S., & Yasaka, M. (2024). Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.64223

Vancouver

Toyoda K, Arakawa S, Ezura M, Kobayashi R, Tanaka Y, Hasegawa S, et al. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan. Journal of Atherosclerosis and Thrombosis. 2024. doi:10.5551/jat.64223

BibTeX
@article{Toyoda2024,
  author = {Toyoda, Kazunori and Arakawa, Shuji and Ezura, Masayuki and Kobayashi, Rei and Tanaka, Yoshihide and Hasegawa, Shu and Yamashiro, Shigeo and Komatsu, Yoji and Terasawa, Yuka and Masuno, Tomohiko and Kobayashi, Hiroshi and Oikawa, Suzuko and Yasaka, Masahiro},
  title = {Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2024},
  doi = {10.5551/jat.64223}
}
Kostenlos starten →